Michael Makris on Non-Malignant Haematology
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared on LinkedIn:
”What do you call the specialty of “non-malignant haematology”?
Everybody agrees that non-malignant haematology is not a good term.
Our US colleagues, backed by ASH, have chosen to go with “Classical Hematology”.
I have discussed this with colleagues in the UK and Europe, and have not met a single haematologist who likes the term Classical Haematology.
We now have a new name proposed: Medical Haematology.
A paper in the British Journal of Haematology discusses this in detail, including why this term is preferred to Classical Haematology, and also how this is integrated with hospital medicine and the future of the specialty.
My personal view is that our specialty should be called Medical not Classical Haematology.”
Read the full article here.
Article: Medical haematology: Repositioning haematology at the centre of medicine
Authors: Cheng Hock Toh, Imelda Bates, Sue Pavord
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight
-
Aug 14, 2026, 18:20Venkata Sagi: Systemic Anticoagulation or Left Atrial Appendage Closure?
-
Aug 14, 2026, 18:02Marios Psychogios: Every Minute Matters in Acute Stroke Care
-
Aug 14, 2026, 17:57Molly Lippold-Meinholz: The Magic of Camp for Kids With Bleeding Disorders
-
Aug 14, 2026, 17:52Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
-
Aug 14, 2026, 17:42Nandini Pethe: Representing MicroHealth at BDC
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration